Skip to content
10-Q

Quarterly Report

OncoMed Pharmaceuticals Inc

0001564590-18-026250

← back to feed
Filed
Nov 1, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Oct 31, 2018 38.63M sh
Shares Diluted Q3 2018 · Sep 30, 2018 38.51M sh
Shares Diluted Q3 2018 · Sep 30, 2018 38.38M sh
Shares Diluted Q3 2018 · Sep 30, 2017 37.66M sh
Shares Diluted Q3 2018 · Sep 30, 2017 37.52M sh
Capex Q3 2018 · Sep 30, 2018 $522K
Capex Q3 2018 · Sep 30, 2017 $484K
Operating Cash Flow Q3 2018 · Sep 30, 2018 −$31.45M
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$72.62M
Short Term Investments Q3 2018 · Sep 30, 2018 $62.45M
Short Term Investments Q3 2018 · Dec 31, 2017 $89.81M
Cash And Equivalents Q3 2018 · Sep 30, 2018 $8.41M
Cash And Equivalents Q3 2018 · Dec 31, 2017 $13.28M
Cash And Equivalents Q3 2018 · Sep 30, 2017 $15.88M
Cash And Equivalents Q3 2018 · Dec 31, 2016 $36.95M
Stockholders Equity Q3 2018 · Sep 30, 2018 $51.72M
Stockholders Equity Q3 2018 · Dec 31, 2017 −$48.6M
Current Liabilities Q3 2018 · Sep 30, 2018 $21.34M
Current Liabilities Q3 2018 · Dec 31, 2017 $93.13M
Total Liabilities Q3 2018 · Sep 30, 2018 $25.43M
Total Liabilities Q3 2018 · Dec 31, 2017 $158.93M
Current Assets Q3 2018 · Sep 30, 2018 $73.19M
Current Assets Q3 2018 · Dec 31, 2017 $105.21M
Total Assets Q3 2018 · Sep 30, 2018 $77.15M
Total Assets Q3 2018 · Dec 31, 2017 $110.32M
Eps Diluted Q3 2018 · Sep 30, 2018 $0.16
Eps Diluted Q3 2018 · Sep 30, 2018 −$0.09
Eps Diluted Q3 2018 · Sep 30, 2017 −$0.28
Eps Diluted Q3 2018 · Sep 30, 2017 −$1.29
Eps Basic Q3 2018 · Sep 30, 2018 $0.16
Eps Basic Q3 2018 · Sep 30, 2018 −$0.09
Eps Basic Q3 2018 · Sep 30, 2017 −$0.28
Eps Basic Q3 2018 · Sep 30, 2017 −$1.29
Sga Expense Q3 2018 · Sep 30, 2018 $3.7M
Sga Expense Q3 2018 · Sep 30, 2018 $12.8M
Sga Expense Q3 2018 · Sep 30, 2017 $3.87M
Sga Expense Q3 2018 · Sep 30, 2017 $12.95M
Rd Expense Q3 2018 · Sep 30, 2018 $10.03M
Rd Expense Q3 2018 · Sep 30, 2018 $26.47M
Rd Expense Q3 2018 · Sep 30, 2017 $12.19M
Rd Expense Q3 2018 · Sep 30, 2017 $51.27M
Net Income Q3 2018 · Sep 30, 2018 $6.12M
Net Income Q3 2018 · Sep 30, 2018 −$3.44M
Net Income Q3 2018 · Sep 30, 2017 −$10.69M
Net Income Q3 2018 · Sep 30, 2017 −$48.53M
Operating Income Q3 2018 · Sep 30, 2018 $5.79M
Operating Income Q3 2018 · Sep 30, 2018 −$5.03M
Operating Income Q3 2018 · Sep 30, 2017 −$11.03M
Operating Income Q3 2018 · Sep 30, 2017 −$49.22M
Revenue Q3 2018 · Sep 30, 2018 $19.52M
Revenue Q3 2018 · Sep 30, 2018 $34.24M
Revenue Q3 2018 · Sep 30, 2017 $5.11M
Revenue Q3 2018 · Sep 30, 2017 $17.52M